Sagimet Biosciences
155 Bovet Road
Suite 303
San Mateo, CA 94402
Website: www.sagimet.com
Email: info@sagimet.com
Phone: (650) 561-8600

Number of Employees: 11-50



A biopharmaceutical company focused on developing novel therapeutics for the treatment of a range of diseases including the liver disease NASH and certain cancers, with focus on targeting dysfunctional metabolic pathways. 3-V Biosciences has unique expertise in FASN biology and believes that targeting FASN provides an intervention point for clinical benefit.

General Management
R&D/Regulatory
Name Title Phone Email
George Kemble, PhD CEO/CSO x5
Dennis Hom CFO/Head, Corporate Development x15 dhom@sagimet.com
William McCulloch Chief Medical Officer
Marie O'Farrell, PhD VP, R&D
Katharine Grimmer Clinical Operations Specialist x13 kgrimmer@sagimet.com
General Management
George Kemble, PhD CEO/CSO 5
Dennis Hom CFO/Head, Corporate Development 15 dhom@sagimet.com
R&D/Regulatory
William McCulloch Chief Medical Officer
Marie O'Farrell, PhD VP, R&D
Katharine Grimmer Clinical Operations Specialist 13 kgrimmer@sagimet.com